Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 1.000 | definitive | 0.986 | 100 | 6 | 1996 | 2020 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.700 | strong | 0.978 | 106 | 4 | 1991 | 2020 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.530 | strong | 1.000 | 3 | 0 | 2002 | 2017 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.420 | strong | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2015 | 2018 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
group | 0.070 | None | 0.857 | 7 | 2 | 2005 | 2019 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
group | 0.070 | None | 0.857 | 7 | 2 | 2005 | 2019 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2017 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2017 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
group | 0.030 | None | 1.000 | 3 | 1 | 2005 | 2019 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2019 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2015 | 2018 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2005 | 2011 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2015 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1983 | 1983 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 |